Advanced Search
  Help
  Liveseek
  Seekbot
Pages from the United Kingdom Pages from Europe in
All Topics Focus on one topic
Government & Politics Home, Garden & Estate Science & Nature Computing
Business & Finance Leisure, Sports & Gambling Health & Nutrition Cars & Motoring
Jobs & Education Entertainment & Culture Travel & Holidays
Health and Nutrition
 75   total results, including  0  0  3 
 
Open all preview windows
1.

Central Nervous System Agents - Central Nervous System Drugs - information page with HONselect  Open preview window
... They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. ... Nootropic Agents ... [05/09/07]
http://www.hon.ch/HONselect/Selection/D15.html | Open link in new window | More pages from www.hon.ch
2.

Nootropics and fast GABA(A) neocortical inhibition  Open preview window
Nootropic Agents Enhance the Recruitment of Fast GABAA Inhibition in Rat Neocortex by ... To address this question, we examined the effects of nootropic agents on excitatory and inhibitory postsynaptic currents (EPSCs and IPSCs) recorded from layer V pyramidal cells in acute slices of somatosensory cortex. ... [16/09/06]
http://nootropics.com/gaba/nootropic.html | Open link in new window | More pages from nootropics.com
3.

CNS Drug Discoveries: What the future holds  Open preview window
... Nootropic drugs or anti-Alzheimer's drugs are one of the largest segments of the neurodegenerative market and accounted for 33% of global sales (US$2.6 billion in 2003 and equivalent to 4% of global CNS drug sales). ... These include the development of antidepressants (Cymbalta), antiepileptic agents (Lyrica and Prialt) glutamate antagonists (Namenda, Lamictal ... [24/01/07]
http://www.leaddiscovery.co.uk/reports/CNS-Drug-Discoveries.html | Open link in new window | More pages from www.leaddiscovery.co.uk
4.

BioPortfolio Bulletin - CNS Disorders Alzheimer's Disease Multiple Sclerosis Attention Deficit Hyperactivity Disorder (ADHD), Insomnia, Depression, Neuropathic  Open preview window
... Nootropic drugs or anti-Alzheimer's drugs are one of the largest segments of the neurodegenerative market and accounted for 33% of global sales (US$2.6 billion in 2003 and equivalent to 4% of global CNS drug sales). ... These include the development of antidepressants (Cymbalta), antiepileptic agents (Lyrica and Prialt) glutamate antagonists (Namenda, Lamictal ... [10/10/06]
http://www.bioportfolio.co.uk/bulletin_59.htm | Open link in new window | More pages from www.bioportfolio.co.uk
5.

Emerging Alzheimer's Disease Therapeutics  Open preview window
... The classes of therapeutics currently indicated for the treatment of Alzheimer's disease (AD) are used either to slow disease progression (e.g., acetyl cholinesterase inhibitors and NMDA/glutamate receptor antagonists) or to alleviate cognitive symptoms (e.g., carnitine acetyltransferase stimulatnts and nootropic agents). ... [23/11/07]
http://www.piribo.com/publications/diseases_conditions/alzheimers/nav001.html | Open link in new window | More pages from www.piribo.com
6.

Focus on Vinpocetine  Open preview window
... (1992) Effects of aspirin, dipyridamole, nifedipine, and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination. ... (1986) Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats. ... [22/05/07]
http://www.priory.com/focus15.htm | Open link in new window | More pages from www.priory.com
7.

Dictionary Contents: N  Open preview window
... n; n0; N10-formyltetrahydrofolate; N1-acetylsulfanilamide; N/2; N(2),N(2)-dimethylguanosine-26-methyltransferase; N(2),N(2)-dimethylguanosine-specific tRNA methyltransferase; N(2)-succinylarginine dihydrolase; N(2)-succinylornithine 5-aminotransferase; N4-acetylsulfanilamide; N-(5-amino-1-ribosyl-4-imidazolylcarbonyl)-L-aspartic acid 5'-phosphate syntheta ... [30/03/07]
http://cancerweb.ncl.ac.uk/omd/contents/N.html | Open link in new window | More pages from cancerweb.ncl.ac.uk
8.

Selegiline - Wikipedia  Open preview window
Selegiline / From Wikipedia / Jump to: navigation, search / Image:Selegiline-structure.png / Selegiline / N-methyl-1-phenyl-N-prop-2-ynyl-propan-2-amine ... It is sometimes used off-label to treat narcolepsy and as a nootropic, as well as for its purported life-extending effects. ... Antiparkinsonian agents [25/04/06]
http://en.wikipedia.org/wiki/Selegiline | Open link in new window | More pages from en.wikipedia.org
9.

PROVIGIL/MODAFINIL: Manufacturer's Insert: Approved Uses  Open preview window
Welcome to IAS / Home / Contact Us / Product / Special Offers / Store ... Psychostimulant and nootropic agents. ... Whilst studies carried out with modafinil and other psychoactive agents have shown a low dependence potential, the possibility of dependence following prolonged use cannot be entirely ruled out. ... [16/08/07]
http://www.antiaging-systems.com/apruses/provigil.htm | Open link in new window | More pages from www.antiaging-systems.com
10.

eMedicine - Mental Retardation : Article by Karen H Harum, MD  Open preview window
> Home / Specialties ... Development of nootropic drugs that may alter cognitive processes positively has been of interest to researchers. ... Interactions Increases effect of other hypotensive agents; TCAs may decrease hypotensive effects Pregnancy B - Usually safe but benefits must outweigh the risks. ...
http://www.emedicine.com/neuro/topic605.htm | Open link in new window | More pages from www.emedicine.com
 
1 | 2 | 3 | 4 | 5 | >
 

About SeekportCompanyPrivacy policyAbout resultsContactAdd a SiteMediseekSeekport Germany  Seekport France  Seekport Spain  Seekport Italy  Seekport Austria 

© 2007 Seekport Internet Technologies UK Ltd
Seekport Internet Technologies GmbH